7OAN
| Nanobody C5 bound to Spike | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein, ... | 著者 | Naismith, J.H, Weckener, M. | 登録日 | 2021-04-19 | 公開日 | 2021-08-11 | 最終更新日 | 2021-10-06 | 実験手法 | ELECTRON MICROSCOPY (3 Å) | 主引用文献 | A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat Commun, 12, 2021
|
|
7OAO
| Nanobody C5 bound to RBD | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, C5 nanobody, ... | 著者 | Naismith, J.H, Mikolajek, H. | 登録日 | 2021-04-19 | 公開日 | 2021-08-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.5 Å) | 主引用文献 | A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat Commun, 12, 2021
|
|
7OAP
| Nanobody H3 AND C1 bound to RBD | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, C1 nanobody, CHLORIDE ION, ... | 著者 | Naismith, J.H, Mikolajek, H. | 登録日 | 2021-04-19 | 公開日 | 2021-08-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.901 Å) | 主引用文献 | A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat Commun, 12, 2021
|
|
7OAQ
| |
7OAU
| |
7OAY
| Nanobody F2 bound to RBD | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, F2 nanobody, Spike protein S1 | 著者 | Naismith, J.H, Mikolajek, H. | 登録日 | 2021-04-20 | 公開日 | 2021-08-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (2.34 Å) | 主引用文献 | A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat Commun, 12, 2021
|
|
7OLZ
| Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06 | 分子名称: | 3-[BENZYL(DIMETHYL)AMMONIO]PROPANE-1-SULFONATE, Nanobody Re5D06, Nanobody Re9F06, ... | 著者 | Aksu, M, Guttler, T, Gorlich, D. | 登録日 | 2021-05-20 | 公開日 | 2021-08-11 | 最終更新日 | 2024-01-31 | 実験手法 | X-RAY DIFFRACTION (1.75 Å) | 主引用文献 | Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies. Embo J., 40, 2021
|
|
7RN0
| |
7RNJ
| S2P6 Fab fragment bound to the SARS-CoV/SARS-CoV-2 spike stem helix peptide | 分子名称: | Monoclonal antibody S2P6 Fab heavy chain, Monoclonal antibody S2P6 Fab light chain, SULFATE ION, ... | 著者 | Snell, G, Czudnochowski, N, Croll, T.I, Nix, J.C, Corti, D, Cameroni, E, Pinto, D, Beltramello, M, Sauer, M.M, Veesler, D. | 登録日 | 2021-07-29 | 公開日 | 2021-08-11 | 最終更新日 | 2024-04-03 | 実験手法 | X-RAY DIFFRACTION (2.67 Å) | 主引用文献 | Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science, 373, 2021
|
|
7COT
| |
7MY8
| |
7OZU
| SARS-CoV-2 RdRp with Molnupiravir/ NHC in the template strand base-paired with A | 分子名称: | Non-structural protein 7, Non-structural protein 8, Product RNA, ... | 著者 | Kabinger, F, Stiller, C, Schmitzova, J, Dienemann, C, Kokic, G, Hillen, H.S, Hoebartner, C, Cramer, P. | 登録日 | 2021-06-28 | 公開日 | 2021-08-18 | 最終更新日 | 2021-09-29 | 実験手法 | ELECTRON MICROSCOPY (3.3 Å) | 主引用文献 | Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat.Struct.Mol.Biol., 28, 2021
|
|
7OZV
| SARS-CoV-2 RdRp with Molnupiravir/ NHC in the template strand base-paired with G | 分子名称: | Non-structural protein 7, Non-structural protein 8, Product RNA, ... | 著者 | Kabinger, F, Stiller, C, Schmitzova, J, Dienemann, C, Kokic, G, Hillen, H.S, Hoebartner, C, Cramer, P. | 登録日 | 2021-06-28 | 公開日 | 2021-08-18 | 最終更新日 | 2021-09-29 | 実験手法 | ELECTRON MICROSCOPY (3.2 Å) | 主引用文献 | Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat.Struct.Mol.Biol., 28, 2021
|
|
7RQG
| Crystal structure of the Nsp3 Y3 domain from SARS-CoV-2 | 分子名称: | Non-structural protein 3 | 著者 | Stogios, P.J, Skarina, T, Chang, C, Di Leo, R, Savchenko, A, Joachimiak, A, Satchell, K.J.F, Center for Structural Genomics of Infectious Diseases (CSGID) | 登録日 | 2021-08-06 | 公開日 | 2021-08-18 | 最終更新日 | 2024-04-03 | 実験手法 | X-RAY DIFFRACTION (2.17 Å) | 主引用文献 | Crystal structure of the Nsp3 Y3 domain from SARS-CoV-2 To Be Published
|
|
7EU2
| |
7F4W
| |
7FDG
| SARS-COV-2 Spike RBDMACSp6 binding to hACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, Spike protein S1 | 著者 | Wang, X, Cao, L. | 登録日 | 2021-07-16 | 公開日 | 2021-08-25 | 最終更新日 | 2022-03-23 | 実験手法 | ELECTRON MICROSCOPY (3.69 Å) | 主引用文献 | Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat Commun, 12, 2021
|
|
7FDH
| SARS-COV-2 Spike RBDMACSp25 binding to hACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, Spike protein S1 | 著者 | Wang, X, Cao, L. | 登録日 | 2021-07-16 | 公開日 | 2021-08-25 | 最終更新日 | 2022-03-23 | 実験手法 | ELECTRON MICROSCOPY (3.72 Å) | 主引用文献 | Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat Commun, 12, 2021
|
|
7FDI
| SARS-COV-2 Spike RBDMACSp36 binding to hACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, Spike protein S1 | 著者 | Wang, X, Cao, L. | 登録日 | 2021-07-16 | 公開日 | 2021-08-25 | 最終更新日 | 2022-03-23 | 実験手法 | ELECTRON MICROSCOPY (3.12 Å) | 主引用文献 | Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat Commun, 12, 2021
|
|
7FDK
| SARS-COV-2 Spike RBDMACSp36 binding to mACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, Spike protein S1 | 著者 | Wang, X, Cao, L. | 登録日 | 2021-07-16 | 公開日 | 2021-08-25 | 最終更新日 | 2022-03-23 | 実験手法 | ELECTRON MICROSCOPY (3.69 Å) | 主引用文献 | Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat Commun, 12, 2021
|
|
7M2P
| |
7OYG
| Dimeric form of SARS-CoV-2 RNA-dependent RNA polymerase | 分子名称: | RNA (5'-R(P*CP*UP*AP*CP*GP*CP*AP*GP*UP*G)-3'), RNA (5'-R(P*UP*GP*CP*AP*CP*UP*GP*CP*GP*UP*AP*G)-3'), SARS-CoV-2 RNA-dependent RNA polymerase (nsp12), ... | 著者 | Jochheim, F.A, Tegunov, D, Hillen, H.S, Schmitzova, J, Kokic, G, Dienemann, C, Cramer, P. | 登録日 | 2021-06-24 | 公開日 | 2021-08-25 | 最終更新日 | 2021-09-01 | 実験手法 | ELECTRON MICROSCOPY (5.5 Å) | 主引用文献 | The structure of a dimeric form of SARS-CoV-2 polymerase Communications Biology, 4, 2021
|
|
7E39
| |
7E3B
| |
7E3C
| |